StockData
Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc. (CODX) balance sheet

CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$0.20+0.00 (+0.87%)

Close on Nov 18, 2026Market cap $1.24MP/E –Yield –

Co-Diagnostics, Inc. balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
43.5%
Operating margin
-6787.6%
Net margin
-6523.0%
Return on equity, FY2025
-125.9%

Financial strength

Current ratio
1.81
Debt to equity
–
Debt to assets
–
Cash to current liabilities
127.5%

Valuation

P/E ratio
–
Price to sales
1.71
Price to book
0.10
Dividend yield
–

See a number that looks wrong?